FN2 Research
Markets, explained.
Cited, no-noise breakdowns of why stocks move — earnings reactions, macro shifts, and the data behind the headlines.
SpaceX Lockup Test: 911 Million Shares Unlock as IPO Pipeline Surges and Reg NMS Faces Rescission
SpaceX's first lockup expiry frees up to 911.5 million insider shares on August 6, potentially tripling the public float of a stock already down 49% from its June high. The test arrives as biotech IPOs accelerate, July saw $29.3 billion in new listings, and the SEC moves to rescind Regulation NMS's trade-through rule.
AI Earnings Reset Meets a Hormuz Reversal: The Market's Split Close
The S&P 500 slipped 0.15% as four AI-linked stocks shed roughly $68 billion in market value despite earnings beats, while energy surged on Brent's jump after Iran published restrictive Strait of Hormuz transit terms. Microsoft's $90 billion quarter offered a counter-narrative, and Friday's payrolls loom.
SpaceX Lockup Test Meets Biotech IPO Pipeline as SEC Rewrites Market Plumbing
SpaceX's first lockup expiry could more than double the public float on August 6. The August IPO calendar is biotech-heavy. And the SEC's proposed rescission of Reg NMS Rules 611 and 610(e) represents the most significant equity market-structure change in two decades.
Two-Front Geopolitical Crossroads: Hormuz De-escalation Meets China's Broadest Retaliation Since the Truce
Markets are pricing a Hormuz peace dividend while China escalates the tech war and the first joint yen intervention since 1998 flags quiet currency stress. The crossroads is whether de-escalation in one theater offsets escalation in another.
Records Hold, Memory Chips Crack: A Market Testing Its Seams
Markets paused near record highs on Thursday as memory stocks cracked on weak guidance despite earnings beats, a potential Strait of Hormuz agreement sent energy and gold higher, and jobless claims came in below expectations — a tape pulled in three directions at once.
A Supply Tsunami Hits US Markets: SpaceX Lockup Unlocks $101B While $5B in Follow-Ons Price
SpaceX's first lockup expiration frees 911 million shares—more than doubling the float—in the same week that Prologis, Celestica, and Twist Bioscience tap equity markets for over $5 billion combined. The market's ability to digest this supply wave is the real test.
Hormuz Deal Hopes Deflate Oil's War Premium — But Three Fronts Keep Risk Bidding
Oil's geopolitical risk premium deflated this week as Iran and Oman reached the final stage of a Strait of Hormuz reopening framework, sending Brent down 5% and dragging oil majors and refiners lower. But Houthi Red Sea attacks on Saudi tankers, Ukraine's escalating drone campaign against Russian refineries, and China's extended coast guard patrols east of Taiwan are keeping the geopolitical risk bid alive — gold surged 4% even as oil fell.
Dow's Fifth Record Masks an AI Bifurcation: Alphabet's $175 Billion AI Reshuffle, Nvidia's SpaceX Lifeline, and the Hormuz Oil Bet
The Dow notched a fifth consecutive record close as Hormuz deal optimism dragged oil below $80, but the Nasdaq snapped its four-day rally on Alphabet's $175 billion AI leadership reshuffle and post-earnings disappointment at AMD and SpaceX — even as Nvidia defied the slide on SpaceX's exclusive adoption of its Vera Rubin platform.
SpaceX's $100 Billion Unlock Meets a Biotech IPO Wave: Can the Market Absorb the Supply?
SpaceX's August 6 lock-up expiration releases roughly $100 billion in newly tradable shares — more than doubling the float — just as a biotech-heavy IPO calendar tests the breadth of the 2026 new-issuance window. The market's capacity to absorb the supply is the real signal.
The Hormuz Relief Rally Has an Expiration Date — and the Market Hasn't Read the Fine Print
A US-Iran memorandum to reopen the Strait of Hormuz drove the S&P 500 to a record close and crude to three-month lows, but the 60-day authorization window may not be long enough to clear a 570-vessel backlog — and an IRGC nuclear vow and Chinese trade retaliation are going unpriced.
Tech Takes a Breather After the Record Run: Rotation or Fatigue?
A day after the S&P 500 and Dow hit record highs on AI-earnings euphoria, the Nasdaq lagged as AMD's in-line guidance disappointed and defensives rotated. The question is whether capital is broadening out or concentrating before a retreat.
SpaceX's $116 Billion Unlock Is the IPO Market's First Real Stress Test
On August 6, 911 million SpaceX shares worth roughly $116 billion become eligible for sale — the first tranche of the largest lockup release in history. With the stock down 37% from its June high and short interest near 30% of float, the unlock is a real-time test of market plumbing against a backdrop of record $700B equity issuance and waning buyback effectiveness.